Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Zhongyun Zhao"'
Autor:
Zongwei Hao, Shengjun Han, Zhongyun Zhao, Zongjun Wu, Hui Xu, Chao Li, Mingming Zheng, Yibin Zhou, Yiqun Du, Zhenyu Yu
Publikováno v:
Food Chemistry: X, Vol 24, Iss , Pp 101919- (2024)
In this study, the formation mechanism, physicochemical properties, and intermolecular interactions of ball milling pretreated high amylose corn starch (HACS)-ferulic acid (FA) complexes were elucidated by density functional theory (DFT) calculations
Externí odkaz:
https://doaj.org/article/055fdb43e3494bc29d963beb5be125d6
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228472 (2020)
BACKGROUND:It is important to achieve the low-density lipoprotein cholesterol (LDL-C) goal recommended by clinical guidelines in managing the risk of cardiovascular (CV) events, however, the current management of LDL-C in actual clinical settings is
Externí odkaz:
https://doaj.org/article/aa44eb78faa142d28b2d153fb8b07228
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Immunotherapies have advanced the treatment of metastatic melanoma; however, they are associated with immune-related toxicities. Patients with pre-existing autoimmune comorbidities are commonly excluded from clinical trials invest
Externí odkaz:
https://doaj.org/article/a7ecd5ff737d4e8cb8179faa213d8f20
Autor:
Howard L. Kaufman, Robert H. I. Andtbacka, Frances A. Collichio, Michael Wolf, Zhongyun Zhao, Mark Shilkrut, Igor Puzanov, Merrick Ross
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-9 (2017)
Abstract Background Traditional response criteria may be insufficient to characterize full clinical benefits of anticancer immunotherapies. Consequently, endpoints such as durable response rate (DRR; a continuous response [complete or partial objecti
Externí odkaz:
https://doaj.org/article/f658eb457d8f4a8389737f99c16ddf40
Publikováno v:
Journal of Skin Cancer, Vol 2014 (2014)
Objective. To describe treatment patterns and factors influencing treatment in a real-world setting of US patients with metastatic melanoma (MM). Methods. This was a retrospective claims-based study among patients with MM diagnosed between 2005 and 2
Externí odkaz:
https://doaj.org/article/4a16b1af3243440a8e780f8353fb353b
Autor:
Fei-Yuan Hsiao, Wen-Jone Chen, Lian-Yu Lin, Yi Qian, Pratik P. Rane, Kathleen M. Fox, Yao-Chun Wen, Li-Jiuan Shen, Zhongyun Zhao
Publikováno v:
Journal of Evaluation in Clinical Practice. 26:1171-1180
Objectives To assess treatment patterns of statin and/or ezetimibe and possible statin intolerance among patients initiating statin or statin plus ezetimibe and with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in
Autor:
Gordon G. Liu, Nathan Williams, Jason Shepherd, H. Bailey, Zhongyun Zhao, Yi Qian, Pratik P. Rane
Publikováno v:
Journal of Drug Assessment
Objective: To describe characteristics of patients with dyslipidemia treated in routine care in China overall and stratified by diabetes and atherosclerotic cardiovascular disease (ASCVD). Methods: This study used data from a cross-sectional survey c
Autor:
Dionne M. Hines, Nicolas Batty, Qiufei Ma, Zhongyun Zhao, Beth Barber, J. Munakata, Yaozhu Juliette Chen
Publikováno v:
Journal of Dermatological Treatment. 28:549-553
This retrospective analysis of the IMS PharMetrics Plus claims database aimed to describe the current real-world treatment patterns for metastatic melanoma in the USA.Included patients (aged ≥18 years) had ≥1 prescription for ipilimumab, vemurafe
Publikováno v:
Journal of Cancer Therapy. :913-923
Background: Melanoma is a rare but serious skin cancer that is responsible for >90% of skin cancer-related deaths. This retrospective data analysis quantifies the direct cost of medical care by disease stage at diagnosis for patients with metastatic
Autor:
Alexandru Dobrescu, Manju Chandran, Isabelle Gagnon-Arpin, Man Yee Mallory Leung, Wenshan Li, Tang Ching Lau, Zhongyun Zhao, Narendra Patil
Publikováno v:
Archives of Osteoporosis. 14
This study aims to estimate the health and economic burden of osteoporosis in Singapore from 2017 to 2035, and to quantify the impact of increasing the treatment rate of osteoporosis. Population forecast data of women and men aged 50 and above in Sin